Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Last week, Fitch Ratings asserted the debt and credit ratings of Allstate Corp. (ALL - Analyst Report) and assigned rating of “BBB+” on the company’s newly issued notes worth $1 billion as well.

Recently, Allstate raised about $1 billion in a two-part note offering. The first tranche of notes worth $500 million were issued for 10 years with a coupon rate of 3.15%. This is expected to yield 102 basis points above the Treasury benchmark. The remaining $500 million of notes were issued for 30 years, bearing a coupon of 4.5% and are projected to yield 122 basis points above the Treasury.

Meanwhile, both sets of notes carry “A3” and “BBB+” ratings from Moody’s investor Service of Moody’s Corp. (MCO - Analyst Report) and Fitch, respectively. The raised debt is expected to be utilized for enhancing the operating leverage of the company.

Simultaneously, Fitch affirmed its issuer default rating (IDR) of “A-“on Allstate. Further, an insurer financial strength (IFS) rating of “A+” was avowed on the company’s property-casualty (P&C) divisions, while an IFS of “A-“ remains static on Allstate’s life insurance and other financial subsidiaries. The outlook for all remains stable.

The rating affirmations exhibit Fitch’s confidence in Allstate’s recent debt refinancing activities, which are likely to improve the financial leverage and reduce the borrowing costs, stemming from the ongoing low interest rate environment. Even the current debt-to-capital ratio of 27.3% at the end of Mar 2013 is well within the rating agency’s benchmark of 28%. Moreover, Allstate is well funded to meet the immediate debt maturity of $250 million, scheduled next month.

On the other hand, with 10% of the market based on premiums written, spurred by favorable underwriting capabilities and strong risk-based capitalization, Allstate holds a leading position in the P&C market. However, uncertainty led by catastrophe losses and sluggishness in the company’s life insurance operations raise some concerns. Although Allstate P&C’s statutory surplus improved to $17.2 billion at the end of Mar 2013, it is still well-below $19.1 billion reported at 2006-end, prior to the financial downturn.

Nevertheless, Fitch believes that Allstate’s overall operating leverage of 2.0x is fairly ahead of its 1.8x benchmark. Going ahead, modest investment gains along with the company’s focus on shifting its life insurance business away from spread-based products should improve Allstate’s risk profile.

While Allstate carries a Zacks Rank #3 (Hold), Moody’s carries a Zacks Rank #2 (Buy). Other outperformers of the insurance sector include Hilltop Holdings Inc. (HTH - Analyst Report) and Montpelier Re (MRH - Analyst Report). Both the stocks carry a Zacks Rank #1 (Strong Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ANI PHARMACE ANIP 29.38 +14.99%
ATLAS FINANC AFH 14.65 +2.85%
ZIOPHARM ONC ZIOP 3.44 +2.08%
ALLIANCE FIB AFOP 17.66 +1.96%
FEDERATED NA FNHC 20.26 +1.96%